Cargando…
CD73 on cancer-associated fibroblasts enhanced by the A(2B)-mediated feedforward circuit enforces an immune checkpoint
CD73, an ecto-5′-nucleotidase (NT5E), serves as an immune checkpoint by generating adenosine (ADO), which suppresses immune activation through the A(2A) receptor. Elevated CD73 levels in tumor tissues correlate with poor clinical outcomes. However, the crucial source of CD73 activity within the tumo...
Autores principales: | Yu, Miao, Guo, Gang, Huang, Lei, Deng, Libin, Chang, Chang-Sheng, Achyut, Bhagelu R., Canning, Madison, Xu, Ningchun, Arbab, Ali S., Bollag, Roni J., Rodriguez, Paulo C., Mellor, Andrew L., Shi, Huidong, Munn, David H., Cui, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6981126/ https://www.ncbi.nlm.nih.gov/pubmed/31980601 http://dx.doi.org/10.1038/s41467-019-14060-x |
Ejemplares similares
-
Inhibitors of the CD73-adenosinergic checkpoint as promising combinatory agents for conventional and advanced cancer immunotherapy
por: Kurago, Zoya, et al.
Publicado: (2023) -
CXCR2-Expressing Tumor Cells Drive Vascular Mimicry in Antiangiogenic Therapy–Resistant Glioblastoma
por: Angara, Kartik, et al.
Publicado: (2018) -
Myeloid cell signatures in tumor microenvironment predicts therapeutic response in cancer
por: Achyut, Bhagelu R, et al.
Publicado: (2016) -
Cancer Therapeutics Following Newton’s Third Law
por: Arbab, Ali S., et al.
Publicado: (2016) -
Arachidonic Acid Metabolite as a Novel Therapeutic Target in Breast Cancer Metastasis
por: Borin, Thaiz F., et al.
Publicado: (2017)